Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARFIP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LIMCH1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MSX2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C1QB - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTH - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MIEF1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RAB3A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DKK3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZBTB20 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WSB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NEDD9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CCDC70 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SEPHS2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ITSN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CAT - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZMIZ2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MAGEC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EXOSC7 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TXNL1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LPAR3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on